FDA Warns Consumers to Stop Using Belviq® (Lorcaserin) Weight Loss Drug Due to Increased Cancer Risk Prescription Drugs
Jason Rager of Wilmington Delaware Predicts Lower Interest Rates Will be a Catalyst for Higher Market Valuations And More Regulations Legislation
